Tilelizumab Txhaj
Lub npe tshuaj: Tilelizumab Txhaj
Cov khoom xyaw: Tilelizumab yog humanized IgG4 anti-PD-1 monoclonal antibody
Cov mis mos molecular: --
Indications: Tilelizumab txhaj yog tsim nyog rau kev kho mob ntawm relapsed los yog refractory classic Hodgkin's lymphoma tom qab tsawg kawg yog thib ob-kab chemotherapy.
Kev txhaj tshuaj Tilelizumab yog siv los kho cov neeg mob uas muaj mob loj heev hauv zos lossis metastatic urothelial carcinoma (UC) nrog siab PD-L1 qhia uas tau ua tsis tiav platinum-muaj tshuaj kho mob, suav nrog tshuaj kho neoadjuvant lossis adjuvant chemotherapy, uas tau nce hauv 12 lub hlis.
Muab cov paclitaxel thiab carboplatin rau thawj kab kev kho mob hauv zos qib siab lossis metastatic squamous uas tsis yog mob qog noj ntshav me me.
Rau thawj kab kev kho mob ntawm cov neeg mob uas tsis yog-squamous non-small cell lung cancer (NSCLC). Tib lub sijhawm, NMPA tau pom zoo tso cai Baizean® rau kev kho mob hepatocellular carcinoma (HCC) cov neeg mob uas tau txais tsawg kawg ib qho kev kho mob.
Specification: 10ml: 100mg
Lub neej txee: 1 xyoos
Cim npe nrov: Tilelizumab txhaj tshuaj, Tuam Tshoj tilelizumab txhaj tshuaj lwm tus neeg







